The role of prostacyclin in lung cancer

作者: Meredith A. Tennis , Michelle Vanscoyk , Robert L. Keith , Robert A. Winn

DOI: 10.1016/J.TRSL.2009.06.010

关键词: ImmunologyAcquired immune systemProstaglandinLung cancerThromboxaneCyclooxygenaseCancer researchMedicineProstacyclinReceptorCancer

摘要: Prostanoids are bioactive lipids that interact with 7-membrane-spanning G-protein–coupled receptors on target cells to impart their biologic effects. 1 They include prostaglandins, prostacyclin, and thromboxane. widely distributed; mediate several diverse effects like platelet aggregation smooth-muscle contraction; known be involved in allergies, acquired immunity, cancer metastasis. 2 have also been associated breast endometrial promotion, the inhibition of melanoma. The role prostanoids development lung disease has poorly understood. In particular, prostacyclin possesses significant anti-inflammatory antimetastatic properties is main product cyclooxygenase-2 activity lung. fact, balance various members family, specifically prosoglandins PGE (PGI ), seems play an increasingly important cancer. Gaining a better understanding pathways critical future molecular-based pharmaceutical treatments disease.

参考文章(54)
Yasushi Hoshikawa, Tracy L. Gesell, Alvin M. Malkinson, Robert L. Keith, York E. Miller, Mark W. Geraci, Heiko A. Golpon, Raphael A. Nemenoff, Bifeng Gao, Mark D. Moore, Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer Cancer Research. ,vol. 62, pp. 734- 740 ,(2002)
Lori D. Dwyer-Nield, Tyler M. Hudish, Richard M. Breyer, S. Patrick Nana-Sinkam, Alvin M. Malkinson, Amy M. Meyer, Robert L. Keith, Mark W. Geraci, Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis Anticancer Research. ,vol. 26, pp. 2857- 2861 ,(2006)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
Tetyana V. Pedchenko, Adriana L. Gonzalez, DingZhi Wang, Raymond N. DuBois, Pierre P. Massion, Peroxisome Proliferator–Activated Receptor β/δ Expression and Activation in Lung Cancer American Journal of Respiratory Cell and Molecular Biology. ,vol. 39, pp. 689- 696 ,(2008) , 10.1165/RCMB.2007-0426OC
Yvette Bren-Mattison, Vicki Van Putten, Daniel Chan, Robert Winn, Mark W Geraci, Raphael A Nemenoff, Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC) Oncogene. ,vol. 24, pp. 1412- 1422 ,(2005) , 10.1038/SJ.ONC.1208333
Kristina M. Fetalvero, Kathleen A. Martin, John Hwa, Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins & Other Lipid Mediators. ,vol. 82, pp. 109- 118 ,(2007) , 10.1016/J.PROSTAGLANDINS.2006.05.011
B. M. Forman, J. Chen, R. M. Evans, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 4312- 4317 ,(1997) , 10.1073/PNAS.94.9.4312
Mauricio J. Reginato, Samuel L. Krakow, Shannon T. Bailey, Mitchell A. Lazar, Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor γ Journal of Biological Chemistry. ,vol. 273, pp. 1855- 1858 ,(1998) , 10.1074/JBC.273.4.1855
M. Wakasugi, T. Noguchi, M. Inoue, Y. Kazama, M. Tawata, Y. Kanemaru, T. Onaya, Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. ,vol. 42, pp. 127- 136 ,(1991) , 10.1016/0090-6980(91)90072-N
Jean Y. Park, Michael H. Pillinger, Steven B. Abramson, Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clinical Immunology. ,vol. 119, pp. 229- 240 ,(2006) , 10.1016/J.CLIM.2006.01.016